Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,792.00
Bid: 1,792.00
Ask: 1,792.50
Change: 14.00 (0.79%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EU mergers and takeovers (Jan 28)

Wed, 28th Jan 2015 18:21

BRUSSELS, Jan 28 (Reuters) - The following are mergers underreview by the European Commission and a brief guide to the EUmerger process:

APPROVALS AND WITHDRAWALS

-- Generic drugmaker Mylan Inc to purchase AbbotLaboratories' specialty and branded generics businessoutside the United States (approved Jan. 28)

-- Swiss drugmaker Novartis to acquire Britishpeer GlaxoSmithKline's oncology products (approved Jan.28)

-- British drugmaker GlaxoSmithKline to acquireNovartis' vaccines business, excluding flu, and thesetting up of a consumer healthcare joint venture (approved Jan.28)

NEW LISTINGS

None

EXTENSIONS AND OTHER CHANGES

None

FIRST-STAGE REVIEWS BY DEADLINE

JAN 28

-- French chemicals producer Arkema to purchaseBlu-Tack maker Bostik from French oil major Total (notified Dec. 12/deadline Jan. 28)

FEB 5

-- Belgian telecoms group Telenet to acquire 50percent stake in Belgian broadcasting company De Vijver Media(notified Aug. 18/deadline extended for the second time to March5 from Feb. 5)

FEB 9

-- Proposed joint venture for 1 gigawatt "Nemo" power linkbetween Belgium and Britain between Britain's National Grid and Belgium's transmission system operator Elia (notified Jan. 5/deadline Feb. 9/simplified)

FEB 12

-- European private equity firm CVC Capital Partners to buy Finnish insulation material maker Paroc for enterprise value of some 700 million euros.(notified Jan. 8/deadline Feb. 12)

FEB 13

-- German conglomerate Siemens to purchase U.S.oilfield equipment maker Dresser-Rand Group Inc (notified Jan. 9/deadline Feb. 13)

-- Japanese building materials and housing equipment groupLIXIL Group Corp to take sole control of sanitoryfittings group Grohe (notified Jan. 9/deadline Feb13/simplified)

FEB 16

-- Private equity firm Bain Capital to acquire Britishbrickmaker Ibstock Group from Irish buidling supplies group CRH (notified Jan. 12/deadline Feb. 16/simplified)

FEB 17

-- Private equity firm Apax Partners to acquire ScandinavianIT services provider Evry (notified Jan. 13/deadline Feb.17/simplified)

FEB 18

-- Canadian asset manager Brookfield Infrastructure Fund to acquire broadcasting and wireless telecominfrastructure platform operator TDF S.A.S.(notified Jan.14/deadline Feb. 18/simplified)

FEB 19

-- Swiss telecoms provider Swisscom and carleasing company Sixt to set up a joint venture (notified Jan.15/deadline Feb. 19/simplified)

FEB 20

-- French minerals company Imerys to acquire rivalS&B Minerals (notified Jan. 15/deadline Feb. 20)

FEB 23

-- U.S. conglomerate General Electric to acquire mostof French engineering group Alstom's power equipmentbusiness (notified Jan. 19/deadline Feb. 23)

-- Commodities trader Cargill to buy rival ArcherDaniels Midland Co's global chocolate business (notifiedJan. 19/deadline Feb. 23)

-- German DIY retailer OBI to acquire a joint venture led byBrico Business Cooperation (notified Jan. 19/deadline Feb.23/simplified)

FEB 25

-- Asset manager The Carlyle Group and private equityfirm Warburg Pincus to jointly acquire control of creditrating agency DBRS Holdings (notified Jan. 21/deadline Feb.25/simplified)

FEB 26

-- German car parts maker ZF Friedrichshafen to buyU.S. peer TRW Automotive Holdings Corp (notified Jan.22/deadline Feb. 26)

FEB 27

-- Canadian private equity firm Onex Corp toacquire aseptic filler machines maker SIG Combibloc Group AG and SIG Holding USA (notified Jan. 23/deadline Feb.27/simplified)

MARCH 5

-- Belgian telecoms group Telenet, which is asubsidiary of U.S. cable group Liberty Global, toacquire 50 percent stake in Belgian broadcasting company DeVijver Media (notified Aug. 18/deadline extended for the secondtime to March 5 from Feb. 5/companies submitted concessions onNov. 24)

APRIL 22

-- SOCAR, Azerbaijan's state energy company, to buy stakesin Greek natural gas grid operator DESFA from Greek natural gasutility DEPA (notified Oct. 1/deadline extended for the secondtime to April 22 from March 23)

APRIL 30

-- French telecoms operator Orange to acquireSpanish provider Jazztel (notified Oct. 16/deadlineextended to April 30 from April 24 after the Commission resumedits scrutiny after a four-day halt)

MAY 13

-- Mondelez International Inc and competitor D.EMaster Blenders to merge their coffee businesses innew company called Jacobs Douwe Egberts (notified Oct.27/deadline extended for the third time to May 13 from May 6)

MAY 29

-- PRS for Music Ltd (PRSfM), Foreningen Svenska TonsattaresInternationella Mysikbyra (Stim) and Gesellschaft fürmusikalische Aufführungs- und mechanischeVervielfältigungsrechte (Gema) to set up a joint venture toadminister mechanical and performing rights (notified Nov.28/deadline extended to May 29 from Jan. 14 after the Commissionopened an in-depth probe)

SUSPENDED

-- U.S. orthopaedic products maker Zimmer Holdings to acquire rival Biomet Inc (notified Aug.29/deadline suspended from Dec. 2, 2014)

GUIDE TO EU MERGER PROCESS

DEADLINES:

The European Commission has 25 working days after a deal is filed for a first-stage review. It may extend that by 10 workingdays to 35 working days, to consider either a company's proposedremedies or an EU member state's request to handle the case.

Most mergers win approval but occasionally the Commission opens a detailed second-stage investigation for up to 90 additional working days, which it may extend to 105 working days.

SIMPLIFIED:

Under the simplified procedure, the Commission announces theclearance of uncontroversial first-stage mergers without givingany reason for its decision. Cases may be reclassified asnon-simplified - that is, ordinary first-stage reviews - untilthey are approved. (Editing by Foo Yun Chee)

More News
Today 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Read more
Today 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Zantac case to go to trial.

Read more
Today 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Read more
Today 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Read more
23 May 2024 19:21

Zantac not a cause of woman’s cancer, jury says in first trial over drug

CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.

Read more
22 May 2024 22:59

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, May 22 (Reuters) -

Read more
21 May 2024 11:23

AstraZeneca aims for $80 bln in total revenue by 2030

Sees $80 bln in 2030 revenue by 2030

*

Read more
21 May 2024 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
21 May 2024 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 17:38

London's FTSE nudges lower for week after record run

Haleon falls after GSK offloads remaining stake

*

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.